Risk-adapted therapy of AML: the AMLCG experience.

Annals of hematology

Volumn 83 Suppl 1, Issue , 2004, Pages

  Kern, W ^a   Haferlach, T ^a   Schoch, C ^a   Sauerland, M C ^a   Heinecke, A ^a   Wormann B ^a   Berdel, W ^a   Buchner T ^a   Hiddemann, W ^a  

^a Medizinische Klinik 1 Schwerpunkt Endokrinologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETICS; HUMAN; IMMUNOLOGY; KARYOTYPING; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURVIVAL;

ADOLESCENT; ADULT; AGED; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 3042525226     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)